Healthcare Value Capital as of March 31, 2019
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 9 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 16.9 | $4.4M | 30k | 146.40 | |
| GlaxoSmithKline | 16.1 | $4.2M | 100k | 41.79 | |
| Tyme Technologies | 14.8 | $3.8M | 2.2M | 1.76 | |
| Viking Therapeutics (VKTX) | 13.4 | $3.5M | 350k | 9.94 | |
| Gilead Sciences (GILD) | 12.5 | $3.3M | 50k | 65.02 | |
| Ligand Pharmaceuticals In (LGND) | 12.1 | $3.1M | 25k | 125.72 | |
| Noveliontherapeuti.. | 8.5 | $2.2M | 1.8M | 1.23 | |
| Antares Pharma | 2.9 | $758k | 250k | 3.03 | |
| Adamas Pharmaceuticals | 2.7 | $711k | 100k | 7.11 |
